Last month, DaVita Clinical Research had a sit-down with one of our research site principal investigators, Dr. Mark Vishnepolsky, to learn more about his insights on providing care to patients… Read more
The world at large received the gifts of hope and relief this year when not only one, but three, Covid-19 vaccinations became available to the masses. Prior to this “light… Read more
The pandemic has brought many changes to the way that we live our lives. One question that remains; how will the pandemic impact a post-pandemic world? We are… Read more
In spite of the comorbid conditions and the high costs of kidney care, the amount of information available for kidney disease patients to participate in clinical trials is limited. For… Read more
Anemia is a common condition that affects most patients with chronic kidney disease (CKD). This condition is when the body lacks enough healthy red blood cells to carry adequate oxygen… Read more
In the age of COVID-19, many things in our daily lives have changed to accommodate and maintain health. This shift has been especially true for the renal industry, as the… Read more
It’s time to celebrate! September 13-19 is Nephrology Nurses Week, a time to recognize the amazing nurses who are the front-line heroes dedicated to supporting research and dialysis patients. Why… Read more
In June 2019, President Trump signed the Advancing American Kidney Health Initiative (AAKHI) executive order, which aims to reduce the number of chronic kidney disease (CKD) patients who progress to… Read more
At DaVita, creating an exceptional, caring experience for our dialysis patients is our top priority. For patients living with chronic kidney conditions, receiving consistent, quality care can make a world… Read more
On May 20, 1747, James Lind, a surgeon aboard a British Royal Navy ship, conducted what is widely believed to be the first clinical trial when he examined the effect… Read more